PPCB Stock Analysis: Buy, Sell, or Hold?
PPCB - Propanc Biopharma, Inc. Common Stock
$1.36
0.18 (15.25%)
▲
5d:
+30.77%
30d:
-24.44%
90d:
+1246.53%
HOLD
MODERATE Confidence
Analysis Updated: Aug 6, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When PPCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PPCB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PPCB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PPCB is currently trading at $1.36, which is considered fair relative to its 30-day fair value range of $1.18 to $1.70.
Technical Outlook: Technically, PPCB is in a strong uptrend. Immediate support is located at $0.95, while resistance sits at $1.60. The stock is showing strong short-term momentum, up 15.3% recently.
Market Sentiment: PPCB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.52 (+11.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PPCB is in a strong uptrend. Immediate support is located at $0.95, while resistance sits at $1.60. The stock is showing strong short-term momentum, up 15.3% recently.
Market Sentiment: PPCB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.52 (+11.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.18 -
$1.70
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+15.3%)
- BULLISH: Trading below Wall St target ($1.52)
Trading Range Analysis
30-Day Trading Range
$1.18 -
$1.70
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.60
Current Trend
Strong Uptrend
Technical data as of
Aug 6, 2026
Fundamental Context
Wall Street Target
$1.52
(+11.8%)
Share & Embed Analysis
Last updated: August 07, 2026 5:15 AM ET
Data refreshes hourly during market hours. Next update: 6:15 AM
Data refreshes hourly during market hours. Next update: 6:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PPCB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 45 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 57 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |